Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
NanoViricides Inc | NNVC | AMEX | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
1,23 | 1,14 | 1,23 | 1,13 | 1,20 |
Actualités Recentes
Date | Heure | Source | Titre |
---|---|---|---|
16/2/2024 | 22:53 | EDGAR2 | Form 8-K - Current report |
14/2/2024 | 22:55 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
19/1/2024 | 22:44 | EDGAR2 | Form 8-K - Current report |
04/12/2023 | 22:08 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
13/10/2023 | 22:30 | EDGAR2 | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
28/9/2023 | 22:44 | EDGAR2 | Form NT 10-K - Notification of inability to timely file Form.. |
01/9/2023 | 22:46 | EDGAR2 | Form 8-K - Current report |
06/7/2023 | 17:16 | IHNW | Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is.. |
04/5/2023 | 12:45 | GLOBE | NanoViricides, Inc. to Present at The Inaugural Ef Hutton.. |